Aurinia Pharmaceuticals Inc.
Pharmaceutical company · Edmonton, Alberta, Canada · Nasdaq: AUPH
Aurinia Pharmaceuticals Inc. is a pharmaceutical company headquartered in Edmonton, Alberta, Canada. Its earliest recorded incorporation is in 2009. Its shares trade on Nasdaq under the ticker AUPH. It has reported private securities offerings to the US SEC, most recently $52 million sold in a notice filed in 2014.
Aurinia Pharmaceuticals at a glance
What does Aurinia Pharmaceuticals do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $52 million sold (2014).
Frequently asked questions about Aurinia Pharmaceuticals
Where is Aurinia Pharmaceuticals headquartered?
Aurinia Pharmaceuticals Inc. is headquartered in Edmonton, Alberta, Canada.
What does Aurinia Pharmaceuticals do?
Aurinia Pharmaceuticals Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Aurinia Pharmaceuticals a public company?
Yes. Aurinia Pharmaceuticals Inc. trades on Nasdaq under the ticker AUPH.
When was Aurinia Pharmaceuticals founded?
The earliest incorporation on record for Aurinia Pharmaceuticals Inc. is in 2009, according to public company registers.
Similar companies
- Aurora Cannabis IncEdmonton, Alberta, Canada
- Entos Pharmaceuticals Inc.Edmonton, Alberta, Canada
- SNDL Inc.Edmonton, Alberta, Canada
- Quest PharmaTech Inc.Edmonton, Alberta, Canada
- AbCellera Biologics Inc.Vancouver, British Columbia, Canada
- Medicenna Therapeutics Corp.Toronto, Ontario, Canada
- Satellos Bioscience Inc.Markham, Ontario, Canada
- Edesa Biotech, Inc.Markham, Ontario, Canada
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences